Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Roche to implement the company's FDA-cleared VENTANA® DP 600 and DP 200 slide scanners. The investment enables pathologists to diagnose patients using digital images and supports future artificial intelligence (AI) integration.
"Labcorp is committed to advancing its diagnostic capabilities through the adoption of innovative technologies," said Marcia Eisenberg, Ph.D., Labcorp's chief scientific officer. "Integrating digital slide scanning into our pathology workflow will help improve accuracy, streamline operations and enable future AI-driven insights."
Labcorp's initiative comes at a critical time for the field of pathology. The U.S. faces a projected shortage of nearly 5,700 pathologists by 2030, while the demand for diagnostic services continues to grow due to an aging population and the increasing incidence of cancer and other diseases.
The digital pathology workflow converts glass slides into high-resolution digital images that can be instantly viewed using a conventional PC workstation (rather than a microscope) and analyzed and shared from any location, eliminating reliance on physical slides and enabling pathologists to operate across different sites.
https://ir.labcorp.com/news-releases/news-release-details/labcorp-announces-collaboration-roche-advance-digital-pathology
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.